EKF Diagnostics Holdings Plc
| London Stock Exchange: EKF
Similar to: LED Medical Diagnostics, Inc.
EKF Diagnostics Holdings Plc manufactures point of care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin. EKF engages in the development, production and distribution of near patient analyzers and manufactures and distributes organ injury biomarkers for acute injury to kidneys, liver and pancreas. It operates through two segments: Manufacture and Sale of Medical Diagnostic Equipment and Other Services. Other Services segment includes the servicing and distribution of other company products under separate distribution agreements. The company's analyzers serve various healthcare professionals, including blood banks, GP surgeries, diabetes clinics, pharmacies, hospitals, sports medicine and laboratories. It also focuses on the design, development, manufacture and selling of diagnostic instruments and reagents and sells ancillary products, including a line of proprietary cuvettes. EKF Diagnostics Holdings was founded in 1990 and is headquartered in Penarth, the United Kingdom.